These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 36851628)

  • 21. Encephalitic alphaviruses.
    Zacks MA; Paessler S
    Vet Microbiol; 2010 Jan; 140(3-4):281-6. PubMed ID: 19775836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. REVIEW PAPER: pathology of animal models of alphavirus encephalitis.
    Steele KE; Twenhafel NA
    Vet Pathol; 2010 Sep; 47(5):790-805. PubMed ID: 20551475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV.
    Phelps AL; O'Brien LM; Ulaeto DO; Holtsberg FW; Liao GC; Douglas R; Aman MJ; Glass PJ; Moyer CL; Ennis J; Zeitlin L; Nagata LP; Hu WG
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3.
    Bakovic A; Bhalla N; Alem F; Campbell C; Zhou W; Narayanan A
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alphavirus antiviral drug development: scientific gap analysis and prospective research areas.
    Reichert E; Clase A; Bacetty A; Larsen J
    Biosecur Bioterror; 2009 Dec; 7(4):413-27. PubMed ID: 20028250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pathology study of Venezuelan, eastern, and western equine encephalitis viruses in non-human primates.
    Smith DR; Schmaljohn CS; Badger C; Ostrowski K; Zeng X; Grimes SD; Rayner JO
    Antiviral Res; 2020 Oct; 182():104875. PubMed ID: 32755661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses.
    Lin SC; Lehman CW; Stewart AK; Panny L; Bracci N; Wright JLC; Paige M; Strangman WK; Kehn-Hall K
    Antiviral Res; 2021 Jul; 191():105087. PubMed ID: 33965437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
    Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
    Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encephalitic Alphaviruses Exploit Caveola-Mediated Transcytosis at the Blood-Brain Barrier for Central Nervous System Entry.
    Salimi H; Cain MD; Jiang X; Roth RA; Beatty WL; Sun C; Klimstra WB; Hou J; Klein RS
    mBio; 2020 Feb; 11(1):. PubMed ID: 32047126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralising antibodies for Mayaro virus in Pantanal, Brazil.
    Pauvolid-Corrêa A; Juliano RS; Campos Z; Velez J; Nogueira RM; Komar N
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):125-33. PubMed ID: 25742272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.
    Phillips AT; Rico AB; Stauft CB; Hammond SL; Aboellail TA; Tjalkens RB; Olson KE
    J Virol; 2016 Jun; 90(12):5785-96. PubMed ID: 27053560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alphavirus protease inhibitors from natural sources: A homology modeling and molecular docking investigation.
    Byler KG; Collins JT; Ogungbe IV; Setzer WN
    Comput Biol Chem; 2016 Oct; 64():163-184. PubMed ID: 27387412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence and Magnitude of ML336 Resistance in Venezuelan Equine Encephalitis Virus Depend on the Microenvironment.
    Lee J; Parvathareddy J; Yang D; Bansal S; O'Connell K; Golden JE; Jonsson CB
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32878897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Quantitative Real-Time RT-PCR Assay for the Detection of
    Vina-Rodriguez A; Eiden M; Keller M; Hinrichs W; Groschup MH
    Biomed Res Int; 2016; 2016():8543204. PubMed ID: 28042576
    [No Abstract]   [Full Text] [Related]  

  • 35. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.
    Chung DH; Jonsson CB; Tower NA; Chu YK; Sahin E; Golden JE; Noah JW; Schroeder CE; Sotsky JB; Sosa MI; Cramer DE; McKellip SN; Rasmussen L; White EL; Schmaljohn CS; Julander JG; Smith JM; Filone CM; Connor JH; Sakurai Y; Davey RA
    PLoS Pathog; 2014 Jun; 10(6):e1004213. PubMed ID: 24967809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.
    Garmashova N; Gorchakov R; Volkova E; Paessler S; Frolova E; Frolov I
    J Virol; 2007 Mar; 81(5):2472-84. PubMed ID: 17108023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Western, Eastern, and Venezuelan Equine Encephalitis (WEVEE) Virus-Replicon Particle (VRP) Vaccine against WEEV in a Non-Human Primate Animal Model.
    Burke CW; Erwin-Cohen RA; Goodson AI; Wilhelmsen C; Edmundson JA; White CE; Glass PJ
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.
    Phillips AT; Schountz T; Toth AM; Rico AB; Jarvis DL; Powers AM; Olson KE
    J Virol; 2014 Feb; 88(3):1771-80. PubMed ID: 24257615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of antibodies to alphaviruses and discrimination between antibodies to eastern and western equine encephalitis viruses in rabbit sera using a recombinant antigen and virus-specific monoclonal antibodies.
    Pässler S; Pfeffer M
    J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):265-9. PubMed ID: 14628996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designing multivalent immunogens for alphavirus vaccine optimization.
    Read CM; Plante K; Rafael G; Rossi SL; Braun W; Weaver SC; Schein CH
    Virology; 2021 Sep; 561():117-124. PubMed ID: 33823988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.